Atlas Trials

Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics

Clinical trial NCT02656069 · COMPLETED

Trial details

NCT number
NCT02656069
Sponsor
Xeris Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HypoglycemiaDiabetes Mellitus, Type 1
Start date
2017-03-15
Primary completion
2017-08-14
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.